You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

VRC07-523LS

Showing 1 - 25 of 63
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

HIV-1-infection Trial in Mbeya (ART, 10E8.4/iMab, VRC07-523LS)

Not yet recruiting
  • HIV-1-infection
  • Mbeya, Tanzania
    National Institute for Medical Research-Mbeya Medical Resarch Ce
Jun 6, 2023

HIV Trial in United States (PGT121.414.LS, VRC07-523LS)

Completed
  • HIV Infections
  • PGT121.414.LS
  • VRC07-523LS
  • Los Angeles, California
  • +4 more
Jan 31, 2023

HIV-1-infection Trial in Umlazi (Vesatolimod, VRC07523LS, CAP256V2LS)

Recruiting
  • HIV-1-infection
  • Umlazi, South Africa
    FRESH Clinical Research Site: Females Rising through Education,
Jan 4, 2023

HIV Trial in Worldwide (VRC01, VRC01LS, VRC07-523LS)

Completed
Has Results
  • HIV Infections
  • VRC01
  • +2 more
  • Los Angeles, California
  • +13 more
Dec 19, 2022

HIV Trial in Worldwide (PGDM1400LS (5mg/kg, IV), PGDM1400LS (20mg/kg, IV), PGDM1400LS (20mg/kg, SC))

Recruiting
  • HIV Infections
  • PGDM1400LS (5mg/kg, IV)
  • +16 more
  • San Francisco, California
  • +13 more
Aug 12, 2022

HIV/AIDS Trial in Orlando, Boston, Houston (PGT121 + VRC07-523LS, PGT121 + VRC07-523LS + PGDM1400)

Completed
  • HIV/AIDS
  • PGT121 + VRC07-523LS
  • PGT121 + VRC07-523LS + PGDM1400
  • Orlando, Florida
  • +2 more
May 6, 2022

HIV Trial in Boston, Seattle (VRC07-523LS)

Completed
Has Results
  • HIV Infections
  • VRC07-523LS
  • Boston, Massachusetts
  • +1 more
Mar 4, 2022

HIV-1-infection Trial in Pathum Wan (VRC07-523LS, PGDM1400LS, N-803)

Not yet recruiting
  • HIV-1-infection
  • VRC07-523LS
  • +7 more
  • Pathum Wan, Bangkok, Thailand
  • +1 more
Mar 8, 2023

HIV Trial in Switzerland, United States (VRC07-523LS, Placebo)

Completed
Has Results
  • HIV Infections
  • VRC07-523LS
  • Placebo
  • Birmingham, Alabama
  • +6 more
Feb 21, 2022

HIV, AIDS, Immunologic Deficiency Syndrome, Acquired Trial in Boston (Ad26.Mos4.HIV, MVA-BN-HIV, PGT121)

Recruiting
  • HIV
  • +4 more
  • Ad26.Mos4.HIV
  • +4 more
  • Boston, Massachusetts
    Beth Israel Deaconess Medical Center
Apr 18, 2022

HIV-1 Infection Trial in Chapel Hill (VRC07-523LS, Vorinostat (VOR))

Completed
Has Results
  • HIV-1 Infection
  • VRC07-523LS
  • Vorinostat (VOR)
  • Chapel Hill, North Carolina
    University of North Carolina Health Care
Nov 4, 2021

HIV-1-infection Trial in Puerto Rico, United States (TMB-365/TMB-380)

Recruiting
  • HIV-1-infection
  • San Francisco, California
  • +6 more
Oct 25, 2022

Healthy Adult Immune Response Trial run by the NIAID (VRC-HIVMAB095-00-AB (10E8VLS), VRC-HIVMAB075-00-AB (VRC07-523LS))

Terminated
Has Results
  • Healthy Adult Immune Response
  • VRC-HIVMAB095-00-AB (10E8VLS)
  • VRC-HIVMAB075-00-AB (VRC07-523LS)
  • Bethesda, Maryland
    National Institutes of Health Clinical Center
Dec 8, 2020

HIV-1 Trial in Puerto Rico, United States (VRC-HIVMAB080-00-AB, VRC-HIVMAB075-00-AB)

Completed
Has Results
  • HIV-1
  • VRC-HIVMAB080-00-AB
  • VRC-HIVMAB075-00-AB
  • Birmingham, Alabama
  • +6 more
Feb 8, 2021

HIV Prevention Trial run by the NIAID (VRC-HIVMAB075-00-AB)

Completed
Has Results
  • HIV Prevention
  • VRC-HIVMAB075-00-AB
  • Bethesda, Maryland
    National Institutes of Health Clinical Center
Oct 21, 2020

HIV Infection Trial in United States (N-803 (IL-15 Superagonist), VRC07-523LS, 10-1074)

Recruiting
  • HIV Infection
  • N-803 (IL-15 Superagonist)
  • +2 more
  • Los Angeles, California
  • +11 more
Sep 22, 2022

Acute HIV Infection Trial in Brazil, Peru, United States (biological, other, drug)

Not yet recruiting
  • Acute HIV Infection
  • VRC07-523LS
  • +3 more
  • Birmingham, Alabama
  • +35 more
Jan 30, 2023

HIV Trial in Boston (PGDM1400/Placebo (3mg/kg IV), PGDM1400/Placebo (10mg/kg IV), PGDM1400/Placebo (30mg/kg IV))

Completed
  • HIV Infections
  • PGDM1400/Placebo (3mg/kg IV)
  • +7 more
  • Boston, Massachusetts
    Beth Israel Deaconess Medical Center
Sep 11, 2020

Hiv, HIV/AIDS, HIV Trial in San Francisco, Boston, Minneapolis (N-803 and bNAbs, haNK™ Cells)

Withdrawn
  • Hiv
  • +5 more
  • N-803 and bNAbs
  • haNK™ Cells
  • San Francisco, California
  • +2 more
Oct 21, 2020

HIV Trial run by the National Institute of Allergy and Infectious Diseases (NIAID) (VRC-HIVMAB0115-00-AB)

Recruiting
  • HIV
  • VRC-HIVMAB0115-00-AB
  • Bethesda, Maryland
    National Institutes of Health Clinical Center
Feb 2, 2023

HIV/AIDS Trial in San Francisco (Combination Intervention)

Active, not recruiting
  • HIV/AIDS
  • Combination Intervention
  • San Francisco, California
    Zuckerberg San Francisco General Hospital, University of Califor
Mar 21, 2022

HIV Trial in South Africa (VRC01.23LS, PGT121.414.LS, PGDM1400LS)

Not yet recruiting
  • HIV Infections
  • VRC01.23LS
  • +2 more
  • Cape Town, Western Cape, South Africa
  • +7 more
Jul 24, 2023

HIV Trial in South Africa, United States (VRC01, VRC01LS)

Completed
Has Results
  • HIV Infections
  • VRC01
  • VRC01LS
  • Cleveland, Ohio
  • +3 more
Oct 6, 2021

Bogalusa Heart Study

Active, not recruiting
  • Atherosclerosis
  • +4 more
    • New Orleans, Louisiana
      Tulane University
    Sep 12, 2022

    Cellulite Trial in Pasadena (Calcium Hydroxyapatite)

    Active, not recruiting
    • Cellulite
    • Calcium Hydroxyapatite
    • Pasadena, California
      K. Kay Durairaj, MD, FACS, A Medical Corporation
    May 31, 2023